4-epi-Edoxaban
✓
데이터 정확도 100%
연중무휴 과학적 지원
⬡
제품 품질에 대한 무관용 원칙

재고 위치

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

1255529-26-04-epi-Edoxaban

● 재고 있음

카탈로그 번호:VE008117
CAS 번호:1255529-26-0
분자식:C24H30ClN7O4S
분자량:548.06 g/mol

에 대한 추가 정보 CAS 1255529-26-0

모약물

Edoxaban

IUPAC명

N1-(5-chloropyridin-2-yl)-N2-((1S, 2R, 4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4, 5, 6, 7-tetrahydrothiazolo[5, 4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide

약전 동의어

N/A

Other Synonyms

Edoxaban SRR Isomer

Smile

O=C(NC1=NC=C(Cl)C=C1)C(N[C@@H]2[C@H](NC(C(S3)=NC4=C3CN(C)CC4)=O)C[C@H](C(N(C)C)=O)CC2)=O

InChI

InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15+,17-/m1/s1

설명

4-epi-Edoxaban is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Edoxaban. 4 epi Edoxaban (1255529-26-0) is an attractive target for anticoagulant treatment. Edoxaban is an oral direct factor Xa inhibitor. It is used in the prevention of stroke and embolism. It is used in the prevention of stroke and embolism.

견적 요청

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url